3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Other neoplasm
1
Conditions
Uterine Cervical Neoplasms
22
Uterine Cervical Dysplasia
15
Papillomavirus Infections
7
Precancerous Conditions
5
Neoplasms
4
Squamous Intraepithelial Lesions
2
Genital Diseases
2
Atypical Squamous Cells of the Cervix
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Sexually Transmitted Diseases, Viral
1
Sexually Transmitted Diseases
1
Papilloma
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
HIV Infections
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Female Urogenital Diseases and Pregnancy Complications
1
Cervical Intraepithelial Neoplasia Grade 2/3
1
Cervical Intraepithelial Neoplasia Grade 1 (CIN 1)
1
Adenocarcinoma in Situ
1
Interventions
Colposcopy
2
serabelisib
1
selinexor
1
sapanisertib
1
padeliporfin
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Pregnancy Tests
1
Paclitaxel
1
Human Papillomavirus DNA Tests
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Genital Diseases
×
Colposcopy
×
Clear all
NCT07281599
2026-02-02
EQUIP
Qurasense
Phase NA
Recruiting
450 enrolled
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled